Botanical Adulteration: BAPP Publishes 100+ Reports, Shifts QC Burden to Manufacturers
The Botanical Adulterants Prevention Program (BAPP) has released over 100 peer-reviewed reports on botanical adulteration, forcing manufacturers to update quality control protocols to counteract sophisticated fraud tactics. Failure to adopt BAPP's recommended analytical methods risks product misrepresentation and regulatory non-compliance.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
New York, United States — 03 June 2026
The Botanical Adulterants Prevention Program (BAPP), a joint initiative by the American Botanical Council (ABC), the American Herbal Pharmacopoeia, and the National Center for Natural Products Research, has surpassed 100 peer-reviewed publications addressing intentional botanical adulteration. This milestone underscores the persistent challenge of raw material fraud within the supplement industry, a problem Mark Blumenthal, ABC's founder and executive director, highlights as continuous and dynamic. These publications, including 17 specific lab guidance documents, are freely accessible, providing critical intelligence for quality control (QC) and procurement teams.
Blumenthal stresses that BAPP's mission extends beyond merely documenting failures; it actively seeks to improve industry practices by exposing outdated analytical methods. Fraudsters continually adapt, often tailoring adulteration to circumvent standard QC checks by mimicking chemical analysis readouts. Manufacturers relying on single-method or non-robust analytical protocols risk authenticating compromised material, leading to product integrity issues and potential regulatory exposure.
The programme's intelligence directly informs manufacturers on which analytical methods are no longer fit for purpose. It advocates for the adoption of comprehensive, multi-method approaches to ensure genuine botanical authentication. This proactive stance on fraud prevention shifts the burden onto manufacturers to consistently update their QC frameworks, influencing raw material specifications and supplier qualification processes. The emphasis on vigilance is paramount for maintaining product claims and consumer trust.
What this means for United Kingdom
UK manufacturers and brand owners must proactively integrate BAPP's extensive findings into their ingredient sourcing and QC strategies to maintain market credibility and regulatory adherence. The Food Standards Agency (FSA) expects robust supply chain due diligence; reliance on inadequate analytical methods constitutes a compliance risk. Expect increased pressure from retailers like Holland & Barrett for enhanced raw material verification. Reformulation windows for products using high-risk botanicals will require careful management, potentially impacting product launch schedules or increasing production costs by 5-10% to accommodate advanced testing. Prioritising suppliers demonstrating BAPP-aligned QC adherence will be crucial for maintaining competitive positioning and margin stability.
BAPP’s sustained effort, funded entirely by donations, provides an essential industry resource. Its work highlights that effective adulteration prevention demands ongoing vigilance and the application of sophisticated analytical science. This intelligence equips businesses to safeguard product authenticity against sophisticated and evolving fraud schemes, protecting both brand reputation and financial performance.
For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.